UNSPSC 51293602: Amedalin

This classification denotes an antidepressant agent, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 2OWK6X9N16. European Medicines Agency schedules Amedalin in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB05406MIG. Amedalin generally arises in the molecular formula C19H22N2O.

UNSPSC 51293602 Amedalin is a Commodity code covering naloxone and related opioid-response pharmaceutical products that state and local health and safety agencies procure for community overdose-prevention and emergency-response programs. Recent state and local solicitations under this code reflect demand from county health departments and public-health bodies seeking to stock naloxone and complementary drug-deactivation systems for distribution to first responders, community health facilities, and public-access emergency-response networks. The work involves straightforward product procurement with vendor responsibility for delivery, compliance with federal funding requirements when FEMA or similar sources support the purchase, and standard commercial insurance and employment-eligibility documentation.

Seminole County, Florida has posted the only recent opportunity visible under this code: IFB 60459723LAS, issued June 30, 2026, seeking 1,900 units of naloxone and 800 safe drug-deactivation systems annually with quarterly deliveries to the Seminole County Community Health Building in Sanford, Florida. The IFB response deadline was July 26, 2023, and the contract included a two-year initial term with a one-year renewal option, fixed-fee pricing, and FEMA-compliant compliance requirements including the Clean Air Act and Federal Water Pollution Control Act. The procurement saw limited visibility in public records and does not reveal broader geographic or multi-jurisdiction activity under this code at present.